Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation
Open Access
- 1 April 1996
- journal article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 49 (4) , 395-400
- https://doi.org/10.1016/0895-4356(95)00058-5
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Problems in the Conduct and Analysis of Randomized Clinical TrialsArchives of internal medicine (1960), 1992
- Effects of cigarette smoking and propranolol in survivors of acute myocardial infarctionThe American Journal of Cardiology, 1990
- Complexity and contradiction in clinical trial researchThe American Journal of Medicine, 1987
- Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.Circulation, 1986
- An alternative interpretation of the results of the Coronary Artery Surgery Study.Circulation, 1985
- Patient subsets and variation in therapeutic efficacy.British Journal of Clinical Pharmacology, 1982
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- Multicentre clinical trials: Bradford Hill's contributions and some subsequent developmentsStatistics in Medicine, 1982
- The Importance of Beta, the Type II Error and Sample Size in the Design and Interpretation of the Randomized Control TrialNew England Journal of Medicine, 1978
- Some Thoughts on Clinical Trials, Especially Problems of MultiplicityScience, 1977